Sheikh Zayed Federal Postgraduate Medical Institute
Clinical trials sponsored by Sheikh Zayed Federal Postgraduate Medical Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Nosebleed breakthrough? new block may beat painful packing Results expected Feb 2027 (estimated)
- Head-to-Head: which JAK inhibitor tames rheumatoid arthritis best? Results expected Mar 2027 (estimated)
- Could low blood protein make a common antibiotic riskier after surgery? Results expected Sep 2027 (estimated)
-
Head-to-Head: which JAK inhibitor tames rheumatoid arthritis best?
Disease control Not yet recruitingThis study will compare two drugs, tofacitinib and upadacitinib, added to standard methotrexate treatment for rheumatoid arthritis. One hundred adults in Pakistan will take one of the two drugs daily for six months. Researchers will measure disease activity and side effects to se…
Phase 4 • Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Hair loss showdown: spray or pill? new study to find out
Disease control Not yet recruitingThis study compares two forms of minoxidil—a topical spray and an oral pill—for treating androgenetic alopecia (common hair loss) in 200 men and women aged 18 to 50. Over 6 months, researchers will measure hair regrowth, shedding, and side effects. Participants will use either th…
Phase 3 • Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Nosebleed breakthrough? new block may beat painful packing
Symptom relief Not yet recruitingThis pilot study will compare two methods for stopping nosebleeds in 40 adults: standard nasal packing and a greater palatine foramen block (an injection of numbing medicine). The main goal is to see which causes less pain and which controls bleeding better. Results will be measu…
Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Could low blood protein make a common antibiotic riskier after surgery?
Knowledge-focused Not yet recruitingThis observational study looks at whether low albumin levels (hypoalbuminemia) increase the risk of bleeding problems (coagulopathy) in patients who receive the antibiotic cefoperazone/sulbactam after surgery. Researchers will follow coagulation tests in about 108 post-operative …
Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC